Shelia Ridner

Lymphedema study results could be a game-changer for breast cancer patients and survivors. The Vanderbilt-led trial found that patients with early detection who used L-Dex with additional intervention were less likely to progress to chronic lymphedema than patients monitored with a tape measure receiving the same intervention.  Read More

Lymphedema study results could be a game-changer for breast cancer patients and survivors. Read More